ArticleActa pharmacologica Sinica2026

Repurposing atorvastatin for uterine leiomyosarcoma: mevalonate pathway inhibition yields preclinical antitumor efficacy.

Fang-Liang Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.